USFDA approves first treatment for patients with liver scarring due to Fatty Liver Disease – Pharma News
The U.S. Food and Drug Administration (USFDA) has approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis...
